Oct 31, 2014 at 11:01 | Source: PTI
An international organisation working for cancer affected people has asked the Obama administration not to pressurise India to reject a compulsory license on a drug for a rare form of leukaemia which would be a de facto endorsement of an excessive price.
Oct 29, 2014 at 16:51 | Source: CNBC-TV18
Discussing the companys results, GV Prasad co-chairman and CEO, DRL, said the quarter has been a flattish one on the back of high R&D expenses. He expects growth to return once launches start happening.
Oct 29, 2014 at 12:18 | Source: Moneycontrol.com
Mangalam Drugs & Organics Ltd has informed BSE that Mrs. Meenal Sukhani has been appointed as Additional Director on the Board of the Company with effect from October 21, 2014. She will be Non - executive director of the Company.
Oct 28, 2014 at 14:55 | Source: Moneycontrol.com
Consolidated net profit of the drug maker jumped 55 percent year-on-year to Rs 630 crore during the quarter led by growth in formulations, US and domestic businesses, and also due to higher other income and lower tax cost.
Oct 28, 2014 at 14:24 | Source: Moneycontrol.com
Trimurthi Drugs & Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on November 08, 2014, to transact the following items of business thereat: 1. To review the performance of the Company.
Oct 28, 2014 at 10:55 | Source: Moneycontrol.com
Parabolic Drugs has submitted a copy of minutes of the proceedings of the 18th Annual General Meeting (AGM) of the Company held on September 30, 2014.
Oct 22, 2014 at 19:05 | Source: Moneycontrol.com
Beryl Drugs has reported a sales total income from operations of Rs 3.33 crore and a net profit of Rs 0.15 crore for the quarter ended Sep '14
Oct 21, 2014 at 16:12 | Source: PTI
Terming the US as a high growth market for the company, the Mumbai-based firm said it aims to grow at around 25 percent in the world's largest drug market.
Oct 20, 2014 at 16:08 | Source: CNBC-TV18
The growth for the international generics, however, remain muted at about 9 percent due to higher base last year.
Oct 15, 2014 at 20:09 | Source: CNBC-TV18
NPPA had issued guidelines in May for regulating prices of non essential drugs. Subsequently, an order was passed in July for regulating prices of 108 non-essential drugs.